Conexeu Sciences Inc. (CNXU) stock
CNXUNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$2.35+0.35 (+17.75%)
Close on Nov 18, 2026Market cap $66.43MP/E –Yield –
Conexeu Sciences r&d expenses
Research and development expenses are spending on new products and technology.
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $270.41K | – |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $66.61K | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $134.66K | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $42.47K | – |
See a number that looks wrong?